Concepts (217)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Asthma | 11 | 2021 | 4383 | 0.87 | Why? |
| Retroperitoneal Fibrosis | 1 | 2018 | 20 | 0.76 | Why? |
| Scopolamine Derivatives | 1 | 2017 | 10 | 0.70 | Why? |
| Tuberous Sclerosis | 1 | 2018 | 63 | 0.70 | Why? |
| Cholinergic Antagonists | 1 | 2017 | 56 | 0.66 | Why? |
| Albuterol | 1 | 2017 | 105 | 0.64 | Why? |
| Adrenergic beta-2 Receptor Agonists | 1 | 2017 | 142 | 0.58 | Why? |
| Japan | 18 | 2021 | 6653 | 0.55 | Why? |
| Smokers | 1 | 2018 | 550 | 0.47 | Why? |
| Smoking | 5 | 2019 | 3358 | 0.44 | Why? |
| Phenotype | 4 | 2018 | 4037 | 0.43 | Why? |
| Pulmonary Disease, Chronic Obstructive | 3 | 2017 | 3832 | 0.42 | Why? |
| Alveolar Epithelial Cells | 1 | 2018 | 1445 | 0.39 | Why? |
| Pulmonary Alveolar Proteinosis | 2 | 2019 | 16 | 0.38 | Why? |
| Respiratory Function Tests | 6 | 2018 | 1755 | 0.31 | Why? |
| Immunoglobulin E | 3 | 2018 | 557 | 0.30 | Why? |
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2019 | 290 | 0.30 | Why? |
| Research Design | 1 | 2020 | 5830 | 0.26 | Why? |
| Sarcoidosis, Pulmonary | 2 | 2017 | 91 | 0.25 | Why? |
| Metyrapone | 1 | 2020 | 36 | 0.22 | Why? |
| Pituitary ACTH Hypersecretion | 1 | 2020 | 44 | 0.21 | Why? |
| Hospitals | 1 | 2021 | 11793 | 0.21 | Why? |
| Eosinophils | 2 | 2018 | 848 | 0.21 | Why? |
| Diagnostic Tests, Routine | 3 | 2021 | 2643 | 0.21 | Why? |
| Pulmonologists | 1 | 2021 | 98 | 0.21 | Why? |
| Respiratory Care Units | 1 | 2021 | 111 | 0.21 | Why? |
| Saliva | 6 | 2021 | 4679 | 0.20 | Why? |
| Forced Expiratory Volume | 3 | 2018 | 632 | 0.20 | Why? |
| Benzamidines | 1 | 2020 | 206 | 0.19 | Why? |
| Leukocyte Count | 2 | 2020 | 3178 | 0.19 | Why? |
| Pregnenediones | 1 | 2020 | 182 | 0.18 | Why? |
| Rhinitis, Allergic, Perennial | 1 | 2018 | 36 | 0.18 | Why? |
| Respiratory Sounds | 2 | 2018 | 294 | 0.18 | Why? |
| Pulmonary Surfactant-Associated Protein A | 1 | 2018 | 40 | 0.18 | Why? |
| Schizophyllum | 1 | 2017 | 4 | 0.18 | Why? |
| Lymphangioleiomyomatosis | 1 | 2018 | 39 | 0.17 | Why? |
| Mycobacterium avium-intracellulare Infection | 1 | 2018 | 59 | 0.17 | Why? |
| Sarcoidosis | 2 | 2018 | 271 | 0.17 | Why? |
| Gastroesophageal Reflux | 1 | 2018 | 124 | 0.17 | Why? |
| alpha 1-Antitrypsin Deficiency | 1 | 2018 | 94 | 0.17 | Why? |
| Mycoplasma pneumoniae | 1 | 2019 | 233 | 0.17 | Why? |
| Aspergillosis, Allergic Bronchopulmonary | 1 | 2017 | 38 | 0.17 | Why? |
| Obesity, Abdominal | 1 | 2018 | 167 | 0.16 | Why? |
| Rhinitis, Allergic, Seasonal | 1 | 2018 | 121 | 0.16 | Why? |
| Pulmonary Emphysema | 1 | 2018 | 122 | 0.16 | Why? |
| Obesity | 2 | 2018 | 7388 | 0.16 | Why? |
| Carbon Monoxide | 1 | 2018 | 167 | 0.16 | Why? |
| Cadherins | 1 | 2017 | 145 | 0.16 | Why? |
| Body Mass Index | 3 | 2018 | 4306 | 0.16 | Why? |
| Pulmonary Surfactant-Associated Protein D | 1 | 2018 | 129 | 0.16 | Why? |
| Albuminuria | 1 | 2017 | 164 | 0.16 | Why? |
| Apoptosis Regulatory Proteins | 1 | 2017 | 202 | 0.16 | Why? |
| Maternal Exposure | 1 | 2018 | 173 | 0.16 | Why? |
| Guanidines | 1 | 2020 | 499 | 0.16 | Why? |
| Intra-Abdominal Fat | 1 | 2018 | 227 | 0.15 | Why? |
| Pneumonia, Mycoplasma | 1 | 2019 | 292 | 0.15 | Why? |
| Hypertension | 1 | 2017 | 8895 | 0.15 | Why? |
| Disease Outbreaks | 2 | 2021 | 27595 | 0.15 | Why? |
| alpha 1-Antitrypsin | 1 | 2018 | 264 | 0.15 | Why? |
| Sputum | 3 | 2020 | 1720 | 0.15 | Why? |
| Respiration Disorders | 1 | 2021 | 526 | 0.15 | Why? |
| Immunoglobulin G | 2 | 2018 | 21571 | 0.14 | Why? |
| Aged | 19 | 2021 | 215776 | 0.14 | Why? |
| Autoimmune Diseases | 2 | 2019 | 1996 | 0.14 | Why? |
| Serine Proteinase Inhibitors | 1 | 2018 | 341 | 0.14 | Why? |
| Eczema | 1 | 2018 | 227 | 0.14 | Why? |
| Cell Adhesion Molecules | 1 | 2017 | 472 | 0.14 | Why? |
| Nasopharynx | 4 | 2021 | 10224 | 0.14 | Why? |
| Genetic Loci | 1 | 2016 | 439 | 0.14 | Why? |
| Administration, Inhalation | 2 | 2019 | 1647 | 0.14 | Why? |
| Aspergillus | 1 | 2017 | 347 | 0.13 | Why? |
| Adiponectin | 1 | 2014 | 123 | 0.13 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.13 | Why? |
| Receptors, Immunologic | 1 | 2017 | 555 | 0.13 | Why? |
| Leptin | 1 | 2014 | 141 | 0.13 | Why? |
| Bronchiectasis | 1 | 2017 | 312 | 0.12 | Why? |
| Male | 25 | 2021 | 367725 | 0.12 | Why? |
| Female | 27 | 2021 | 380317 | 0.12 | Why? |
| Adult | 20 | 2021 | 244371 | 0.11 | Why? |
| Humans | 38 | 2021 | 930598 | 0.11 | Why? |
| Bronchodilator Agents | 1 | 2017 | 444 | 0.11 | Why? |
| Middle Aged | 21 | 2021 | 270681 | 0.11 | Why? |
| Genetic Predisposition to Disease | 2 | 2017 | 4027 | 0.11 | Why? |
| Respiration | 1 | 2017 | 729 | 0.11 | Why? |
| Polymerase Chain Reaction | 3 | 2021 | 6740 | 0.11 | Why? |
| Glomerular Filtration Rate | 1 | 2017 | 1262 | 0.11 | Why? |
| Young Adult | 8 | 2021 | 93724 | 0.11 | Why? |
| Neutrophils | 2 | 2018 | 5476 | 0.11 | Why? |
| Immunohistochemistry | 1 | 2018 | 2275 | 0.11 | Why? |
| Rhinitis, Allergic | 1 | 2017 | 704 | 0.10 | Why? |
| Autoantibodies | 2 | 2019 | 2094 | 0.10 | Why? |
| Pyrazines | 1 | 2020 | 1783 | 0.10 | Why? |
| Rhinitis | 1 | 2017 | 626 | 0.10 | Why? |
| Metabolic Syndrome | 1 | 2017 | 810 | 0.10 | Why? |
| Amides | 1 | 2020 | 1864 | 0.10 | Why? |
| Cluster Analysis | 1 | 2018 | 3001 | 0.10 | Why? |
| Sinusitis | 1 | 2017 | 649 | 0.10 | Why? |
| Drug Resistance, Bacterial | 1 | 2019 | 1414 | 0.10 | Why? |
| Acute Lung Injury | 1 | 2017 | 904 | 0.09 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2018 | 2309 | 0.09 | Why? |
| Case-Control Studies | 4 | 2020 | 17671 | 0.09 | Why? |
| Pulmonary Diffusing Capacity | 2 | 2019 | 191 | 0.09 | Why? |
| Tomography, X-Ray Computed | 7 | 2020 | 25144 | 0.09 | Why? |
| Time Factors | 3 | 2021 | 31397 | 0.09 | Why? |
| Biomarkers | 4 | 2018 | 23361 | 0.08 | Why? |
| Lung | 5 | 2019 | 31049 | 0.08 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.08 | Why? |
| Membrane Proteins | 1 | 2017 | 1733 | 0.08 | Why? |
| Disease Progression | 4 | 2020 | 13580 | 0.08 | Why? |
| Nucleic Acid Amplification Techniques | 1 | 2020 | 3388 | 0.08 | Why? |
| Convalescence | 1 | 2017 | 2829 | 0.08 | Why? |
| Sex Factors | 2 | 2021 | 11014 | 0.08 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2017 | 3607 | 0.08 | Why? |
| Specimen Handling | 2 | 2021 | 6190 | 0.08 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.07 | Why? |
| Severity of Illness Index | 5 | 2021 | 48226 | 0.07 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.07 | Why? |
| Rural Population | 1 | 2017 | 2408 | 0.07 | Why? |
| Risk Assessment | 2 | 2020 | 25439 | 0.07 | Why? |
| Age of Onset | 2 | 2017 | 557 | 0.07 | Why? |
| Life Style | 1 | 2017 | 2708 | 0.07 | Why? |
| Molecular Diagnostic Techniques | 1 | 2020 | 4239 | 0.07 | Why? |
| Radiography, Thoracic | 2 | 2018 | 5486 | 0.07 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.07 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.06 | Why? |
| Immunologic Factors | 1 | 2019 | 4206 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.06 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.06 | Why? |
| Surveys and Questionnaires | 3 | 2018 | 43792 | 0.06 | Why? |
| ACTH-Secreting Pituitary Adenoma | 1 | 2020 | 29 | 0.06 | Why? |
| Dihydrotestosterone | 1 | 2020 | 39 | 0.06 | Why? |
| Gene Frequency | 2 | 2017 | 1210 | 0.06 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 170 | 0.05 | Why? |
| RNA, Ribosomal, 23S | 1 | 2019 | 25 | 0.05 | Why? |
| Prevalence | 5 | 2021 | 25773 | 0.05 | Why? |
| Tetracycline | 1 | 2019 | 33 | 0.05 | Why? |
| Retrospective Studies | 3 | 2020 | 105322 | 0.05 | Why? |
| Pneumoconiosis | 1 | 2017 | 4 | 0.05 | Why? |
| RNA, Viral | 3 | 2021 | 32276 | 0.05 | Why? |
| Fluorescence | 1 | 2020 | 475 | 0.05 | Why? |
| Levofloxacin | 1 | 2019 | 115 | 0.05 | Why? |
| Receptors, Scavenger | 1 | 2017 | 24 | 0.05 | Why? |
| Cadherin Related Proteins | 1 | 2017 | 3 | 0.04 | Why? |
| Child | 4 | 2021 | 70012 | 0.04 | Why? |
| Adenoma | 1 | 2020 | 215 | 0.04 | Why? |
| Anthropometry | 1 | 2018 | 233 | 0.04 | Why? |
| Enzyme-Linked Immunosorbent Assay | 3 | 2018 | 7868 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Walk Test | 1 | 2019 | 461 | 0.04 | Why? |
| Vital Capacity | 1 | 2018 | 399 | 0.04 | Why? |
| Genetic Heterogeneity | 1 | 2016 | 77 | 0.04 | Why? |
| Adiposity | 1 | 2018 | 329 | 0.04 | Why? |
| Phagocytosis | 1 | 2017 | 409 | 0.04 | Why? |
| Prospective Studies | 2 | 2018 | 43301 | 0.04 | Why? |
| Macrolides | 1 | 2019 | 369 | 0.04 | Why? |
| Mucins | 1 | 2016 | 147 | 0.04 | Why? |
| Odds Ratio | 2 | 2017 | 5861 | 0.04 | Why? |
| Inflammation | 1 | 2017 | 13255 | 0.04 | Why? |
| Delivery of Health Care | 1 | 2021 | 15909 | 0.04 | Why? |
| Infusions, Intravenous | 1 | 2018 | 1224 | 0.03 | Why? |
| Eye | 1 | 2018 | 374 | 0.03 | Why? |
| Cohort Studies | 1 | 2017 | 36005 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Lipopolysaccharides | 1 | 2017 | 848 | 0.03 | Why? |
| Lipid Metabolism | 1 | 2017 | 572 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2019 | 2324 | 0.03 | Why? |
| Mice, Knockout | 1 | 2017 | 1815 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Chemokines | 1 | 2018 | 1095 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2020 | 3395 | 0.03 | Why? |
| Workload | 1 | 2021 | 1887 | 0.03 | Why? |
| Safety | 1 | 2018 | 1583 | 0.03 | Why? |
| HLA Antigens | 1 | 2016 | 830 | 0.02 | Why? |
| Nitric Oxide | 1 | 2017 | 769 | 0.02 | Why? |
| Alleles | 1 | 2016 | 1557 | 0.02 | Why? |
| Regression Analysis | 1 | 2017 | 2484 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2019 | 3786 | 0.02 | Why? |
| Neurosurgical Procedures | 1 | 2020 | 1738 | 0.02 | Why? |
| Genome-Wide Association Study | 1 | 2016 | 1648 | 0.02 | Why? |
| Double-Blind Method | 1 | 2019 | 5988 | 0.02 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.02 | Why? |
| Apoptosis | 1 | 2017 | 2335 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2020 | 2955 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.02 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.02 | Why? |
| Skin | 1 | 2018 | 2096 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| Oxygen | 1 | 2019 | 3715 | 0.02 | Why? |
| Gene Expression | 1 | 2016 | 3332 | 0.02 | Why? |
| Survival Analysis | 1 | 2018 | 7592 | 0.02 | Why? |
| Azithromycin | 1 | 2019 | 3943 | 0.02 | Why? |
| Symptom Assessment | 1 | 2017 | 4967 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.01 | Why? |
| Cross-Sectional Studies | 2 | 2017 | 53120 | 0.01 | Why? |
| Mutation | 1 | 2019 | 12376 | 0.01 | Why? |
| Mice | 1 | 2017 | 21357 | 0.01 | Why? |
| Pneumonia | 1 | 2017 | 5652 | 0.01 | Why? |
| Quality of Life | 1 | 2018 | 9820 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Risk Factors | 2 | 2017 | 71621 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.01 | Why? |
| Infant, Newborn | 1 | 2017 | 23105 | 0.01 | Why? |
| Infant | 1 | 2017 | 30274 | 0.01 | Why? |
| Treatment Outcome | 1 | 2020 | 51732 | 0.01 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.01 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
Konno's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(217)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(77)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_